blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3980561

EP3980561 - COMPOSITIONS AND METHODS FOR TREATING LUNG, COLORECTAL AND BREAST CANCER [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  19.04.2024
Database last updated on 24.08.2024
FormerRequest for examination was made
Status updated on  11.03.2022
FormerThe international publication has been made
Status updated on  11.12.2020
Formerunknown
Status updated on  17.06.2020
Most recent event   Tooltip19.04.2024Application deemed to be withdrawnpublished on 22.05.2024  [2024/21]
Applicant(s)For all designated states
Sitokine Limited
2 Duke Street
London W1U 3EH / GB
[2022/15]
Inventor(s)01 / KORNMAN, Kenneth S.
920 Centre Street
Newton, Massachusetts 02459 / US
02 / DOUCETTE-STAMM, Lynn
14 Flanagan Drive
Framingham, Massachusetts 01701 / US
03 / DUFF, Gordon W.
18 Ashgate Road
Sheffield South Yorkshire S10 3BZ / GB
 [2022/15]
Representative(s)Cooley (UK) LLP
22 Bishopsgate
London EC2N 4BQ / GB
[2022/15]
Application number, filing date20731071.505.06.2020
[2022/15]
WO2020EP65692
Priority number, dateUS201962858147P06.06.2019         Original published format: US 201962858147 P
[2022/15]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020245402
Date:10.12.2020
Language:EN
[2020/50]
Type: A1 Application with search report 
No.:EP3980561
Date:13.04.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 10.12.2020 takes the place of the publication of the European patent application.
[2022/15]
Search report(s)International search report - published on:EP10.12.2020
ClassificationIPC:C12Q1/6886
[2022/15]
CPC:
C12Q1/6886 (EP,US); A61K39/3955 (US); A61K31/136 (US);
A61K31/196 (US); A61K31/325 (US); A61K31/337 (US);
A61K31/404 (US); A61K31/407 (US); A61K31/4184 (US);
A61K31/436 (US); A61K31/444 (US); A61K31/4545 (US);
A61K31/4706 (US); A61K31/4745 (US); A61K31/475 (US);
A61K31/506 (US); A61K31/513 (US); A61K31/517 (US);
A61K31/519 (US); A61K31/5377 (US); A61K31/675 (US);
A61K31/704 (US); A61K31/7048 (US); A61K31/7068 (US);
A61K38/12 (US); A61K38/14 (US); A61P35/00 (US);
C07K16/245 (US); C07K16/248 (US); G01N33/57419 (US);
G01N33/57423 (US); C12Q2600/106 (EP); C12Q2600/118 (EP,US);
C12Q2600/156 (EP,US); C12Q2600/172 (EP); G01N2800/50 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/15]
TitleGerman:ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG VON LUNGEN-, KOLOREKTAL- UND BRUSTKREBS[2022/15]
English:COMPOSITIONS AND METHODS FOR TREATING LUNG, COLORECTAL AND BREAST CANCER[2022/15]
French:COMPOSITIONS ET MÉTHODES DE TRAITEMENT DES CARCINOMES PULMONAIRES, COLORECTAUX ET MAMMAIRES[2022/15]
Entry into regional phase05.01.2022National basic fee paid 
05.01.2022Designation fee(s) paid 
05.01.2022Examination fee paid 
Examination procedure05.01.2022Examination requested  [2022/15]
05.01.2022Date on which the examining division has become responsible
22.07.2022Amendment by applicant (claims and/or description)
03.01.2024Application deemed to be withdrawn, date of legal effect  [2024/21]
23.01.2024Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2024/21]
Fees paidRenewal fee
27.06.2022Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
30.06.202304   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]US2017198350  (DOUCETTE-STAMM LYNN [US], et al) [Y] 1-156 * claims 1-8,38-48,85-88 * * paragraphs [0032] - [0042] - [0044] , [0051] - [0052] - [0056] , [0063] - [0069] * * tables 1-2 *;
 [Y]WO2018234879  (NOVARTIS AG [CH]) [Y] 1-156 * claims 1-14,19,27,28,49,59 * * page 12, paragraph 2 - page 15, paragraph 1 *;
 [Y]  - TATIANA ZAMAY ET AL, "Current and Prospective Protein Biomarkers of Lung Cancer", CANCERS, (20171113), vol. 9, no. 12, doi:10.3390/cancers9110155, page 155, XP055725584 [Y] 17,57,79 * the whole document * * table 1 *

DOI:   http://dx.doi.org/10.3390/cancers9110155
 [Y]  - HUMAID O. AL-SHAMSI ET AL, "Molecular spectrum of KRAS, NRAS, BRAF, PIK3CA, TP53, and APC somatic gene mutations in Arab patients with colorectal cancer: determination of frequency and distribution pattern", JOURNAL OF GASTROINTESTINAL ONCOLOGY, (20161201), vol. 7, no. 6, doi:10.21037/jgo.2016.11.02, ISSN 2078-6891, pages 882 - 902, XP055725587 [Y] 32-34,38,42,83-85,89,90,110 * the whole document * * table 2 *

DOI:   http://dx.doi.org/10.21037/jgo.2016.11.02
 [Y]  - D. Zhang C. Bao H. Qian, "Two variants of Interleukin-1B gene are associated with the decreased risk, clinical features, and better overall survival of colorectal cancer: a two-center case-control study", AGING, (20181219), pages 4084 - 4092, URL: https://paperchase-aging.s3-us-west-1.amazonaws.com/pdf/QmgtQHNJ5vd8747RJ.pdf, (20200825), XP055724820 [Y] 1-156 * the whole document *

DOI:   http://dx.doi.org/10.18632/aging.101695
 [Y]  - XIAOAN LIU ET AL, "Three polymorphisms in interleukin-1Î2 gene and risk for breast cancer: a meta-analysis", BREAST CANCER RESEARCH AND TREATMENT, KLUWER ACADEMIC PUBLISHERS, BO, (20100501), vol. 124, no. 3, doi:10.1007/S10549-010-0910-3, ISSN 1573-7217, pages 821 - 825, XP019859280 [Y] 1-156 * the whole document *

DOI:   http://dx.doi.org/10.1007/s10549-010-0910-3
 [Y]  - WU K S ET AL, "Influence of interleukin-1 beta genetic polymorphism, smoking and alcohol drinking on the risk of non-small cell lung cancer", CLINICA CHIMICA ACTA, ELSEVIER BV, AMSTERDAM, NL, vol. 411, no. 19-20, ISSN 0009-8981, (20101009), pages 1441 - 1446, (20100604), XP027170965 [Y] 1-156 * the whole document *
 [Y]  - KEITH D. EATON ET AL, "Inflammatory Gene Polymorphisms in Lung Cancer Susceptibility", JOURNAL OF THORACIC ONCOLOGY, US, (20180501), vol. 13, no. 5, doi:10.1016/j.jtho.2018.01.022, ISSN 1556-0864, pages 649 - 659, XP055724883 [Y] 1-156 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.jtho.2018.01.022
 [Y]  - BALASUBRAMANIAN SP ET AL, "Interleukin gene polymorphisms and breast cancer: a case control study and systematic literature review", BMC CANCER, BIOMED CENTRAL, LONDON, GB, (20060714), vol. 6, no. 1, doi:10.1186/1471-2407-6-188, ISSN 1471-2407, page 188, XP021016183 [Y] 1-56 * the whole document *

DOI:   http://dx.doi.org/10.1186/1471-2407-6-188
 [Y]  - A. L. VAN DYKE ET AL, "Cytokine and Cytokine Receptor Single-Nucleotide Polymorphisms Predict Risk for Non-Small Cell Lung Cancer among Women", CANCER EPIDEMIOLOGY, BIOMARKERS & PREVENTION, (20090601), vol. 18, no. 6, doi:10.1158/1055-9965.EPI-08-0962, ISSN 1055-9965, pages 1829 - 1840, XP055725150 [Y] 1-156 * the whole document * * table 2 * * page 1835, column 1, paragraph 2 - page 1838, column 2 *

DOI:   http://dx.doi.org/10.1158/1055-9965.EPI-08-0962
 [Y]  - KRISTINA L. BONDURANT ET AL, "Interleukin genes and associations with colon and rectal cancer risk and overall survival", INTERNATIONAL JOURNAL OF CANCER, US, (20120626), vol. 132, no. 4, doi:10.1002/ijc.27660, ISSN 0020-7136, pages 905 - 915, XP055725157 [Y] 1-156 * the whole document *

DOI:   http://dx.doi.org/10.1002/ijc.27660
by applicantUS4683195
 US4683202
 EP0235726
 WO8911548
 US4988617
 US4988167
 US5118801
 US5210015
 WO9322456
 US5270184
 US5312728
 WO9416101
 US5399491
 US5422252
 US5494810
 US5498531
 US5527675
 US5539082
 US5538848
 US5623049
 WO9731256
 US5686246
 US5698399
 US5714331
 US5808918
 US5830711
 US5866336
 US6027923
 US6027889
 US6054564
 US6108635
 US6117635
 WO0056927
 US6140047
 US6210877
 US6251598
 US6268148
 US6268142
 US6383775
 US6437216
 US2002182612
 US6524795
 US6551785
 US6558905
 US2003100031
 US2003124524
 US2003152947
 US2003175764
 US2003235890
 US6706478
 US6713253
 US6720141
 US6730476
 US6733967
 US6746839
 US2004110168
 US2004152124
 US2005032077
 US2005064453
 US2005171338
 US2005282198
 US2006183161
 US2006252050
 US2007264645
 US2007275104
 US2008118920
 US2008187920
 US2008199865
 US2008254476
 US2008254477
 US2008254478
 US2008311581
 US2009023147
 US2009093396
 US2009163460
 US2009170105
 US2009191564
 US2010028893
 US2010098775
 US2010098809
 US2010105038
 US2010112570
 US7723028
 US2010129798
 US2010136561
 US2010255475
 US7820383
 US2010279280
 US2011008906
 US8101360
 US8105775
 US2012208187
 US2013011841
 US2013337448
    - LI et al., Proc Natl Acad Sci USA., (20030000), vol. 100, no. 5, pages 2674 - 8
    - SONG ZYUN LINYE XFENG CLU Y et al., "IL-la and IL-6 expression in cervical cancer", Med Sci Monit, (20160000), vol. 22, pages 4475 - 4481
    - WUWALLACE, Genomics, (19890000), vol. 4, page 560
    - LANDEGREN et al., Science, (19880000), vol. 241, page 1077
    - GUATELLI et al., Proc Natl Acad Sci USA, (19900000), vol. 87, page 1874
    - KWOK, "Methods for genotyping single nucleotide polymorphisms", Annu Rev Genom Hum Genet, (20010000), vol. 2, doi:10.1146/annurev.genom.2.1.235, pages 235 - 58, XP001153175

DOI:   http://dx.doi.org/10.1146/annurev.genom.2.1.235
    - COREY, "Peptide nucleic acids: expanding the scope of nucleic acid recognition", Trends Biotechnol, (19970600), vol. 15, no. 6, doi:10.1016/S0167-7799(97)01037-8, pages 224 - 9, XP004064511

DOI:   http://dx.doi.org/10.1016/S0167-7799(97)01037-8
    - HYRUP et al., "Peptide nucleic acids (PNA): synthesis, properties and potential applications", Bioorg Med Chem, (19960100), vol. 4, no. 1, doi:10.1016/0968-0896(95)00171-9, pages 5 - 23, XP000602327

DOI:   http://dx.doi.org/10.1016/0968-0896(95)00171-9
    - MYERS et al., Nature, (19850000), vol. I ; II, page 495
    - SAIKI et al., Nature, (19860000), vol. I-IV, pages 163 - 166
    - KINZLER KWVOGELSTEIN B., "Landscaping the cancer terrain", Science, (19980000), vol. 154 ; 155, pages 1036 - 1037
    - GIBBS, Nucleic Acid Res, (19890000), vol. 17, pages 2427 - 2448
    - LIVAK et al., PCR Method Appl, (19950000), vol. 4, pages 357 - 362
    - TYAGI et al., Nature Biotechnology, (19960000), vol. 14, pages 303 - 308
    - NAZARENKO et al., Nuc' Acids Res, (19970000), vol. 25, pages 2516 - 2521
    - SRIVATSAN et al., PLoS Genet, (20080000), vol. 4, page el00139
    - RASMUSSEN et al., Nature, (20100000), vol. 463, pages 311 - 317
    - PELAK et al., PLoS Genet, (20100000), vol. 6, page elOOl 111
    - RAM et al., Syst Biol Reprod Med, (20110000), vol. 57, no. 3, pages 117 - 118
    - MCELLISTREM, Future Microbiol, (20090000), vol. 4, pages 857 - 865
    - LO et al., Clin Chem, (20090000), vol. 55, pages 607 - 608
    - ROBINSON, Genome Biol, (20100000), vol. 11, page 144
    - CHEN et al., "Single nucleotide polymorphism genotyping: biochemistry, protocol, cost and throughput", Pharmacogenomics J, (20030000), vol. 3, no. 2, doi:10.1038/sj.tpj.6500167, pages 77 - 96, XP009088626

DOI:   http://dx.doi.org/10.1038/sj.tpj.6500167
    - KWOK et al., "Detection of single nucleotide polymorphisms", Curr Issues Mol Biol, (20030400), vol. 5, no. 2, pages 43 - 60
    - SHI, "Technologies for individual genotyping: detection of genetic polymorphisms in drug targets and disease genes", Am J Pharmacogenomics, (20020000), vol. 2, no. 3, doi:10.2165/00129785-200202030-00005, pages 197 - 205, XP009065150

DOI:   http://dx.doi.org/10.2165/00129785-200202030-00005
    - MAMELLOS, "High-throughput SNP analysis for genetic association studies", Curr Opin Drug Disc Devel, (20030500), vol. 6, no. 3, pages 317 - 21
    - WISE et al., "A standard protocol for single nucleotide primer extension in the human genome using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry", Rapid Comm. Mass Spect, (20030000), vol. 17, no. 11, pages 1195 - 202
    - COHEN et al., Adv Chromatogr, (19960000), vol. 36, pages 127 - 162
    - GRIFFIN et al., Appl Biochem Biotechnol, (19930000), vol. 38, pages 147 - 159
    - ORITA et al., Proc. Nat. Acad
    - RIDKER P.M.BURING J.ECOOK N.R.RIFAI N., "C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy american women", Circulation, (20030000), vol. 107, pages 391 - 397
    - RIDKER P.MDANIELSON EFONSECA F.A et al., "Rosuvastatin to prevent vascular events in men and women with elevated c-reactive protein", The New England Journal of Medicine, (20080000), vol. 359, pages 2195 - 2207
    - RIDKER P.M.HENNEKENS C.H.BURING J.E.RIFAI N, "C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women", The New England Journal of Medicine, (20000000), vol. 342, doi:10.1056/NEJM200003233421202, pages 836 - 843, XP009035223

DOI:   http://dx.doi.org/10.1056/NEJM200003233421202
    - NETEA M.G.BALKWILL FCHONCHOL M et al., "A guiding map for inflammation", Nat Immunol, (20170000), vol. 18, pages 826 - 831
    - RIDKER P.M.EVERETT B.M.THUREN T. et al., "Antiinflammatory therapy with canakinumab for atherosclerotic disease", The New England Journal of Medicine, (20170000), vol. 377, doi:10.1056/NEJMoa1707914, pages 1119 - 1131, XP055524405

DOI:   http://dx.doi.org/10.1056/NEJMoa1707914
    - RIDKER P.M.MACFADYEN J.G.EVERETT B.M. et al., "Relationship of c-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial", Lancet, (20180000), vol. 391, pages 319 - 328
    - RIDKER P.M.MACFADYEN J.G.THUREN T et al., "Effect of interleukin-lbeta inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial", Lancet, (20170000), vol. 390, pages 1833 - 1842
    - RIDKER PM, "Anti-inflammatory therapy for atherosclerosis: interpreting divergent results from the CANTOS and CIRT clinical trials", J Intern Med, (20190000), vol. 285, pages 503 - 9
    - ADAY AWRIDKER PM, "Targeting Residual Inflammatory Risk: A Shifting Paradigm for Atherosclerotic Disease", Front Cardiovasc Med, (20190000), vol. 6, page 16
    - AGGARWAL BBSHISHODIA SSANDUR SKPANDEY MKSETHI G., "Inflammation and cancer: how hot is the link?", Biochem Pharmacol, (20060000), vol. 72, doi:10.1016/j.bcp.2006.06.029, pages 1605 - 21, XP025043230

DOI:   http://dx.doi.org/10.1016/j.bcp.2006.06.029
    - AGGARWAL BBVIJAYALEKSHMI RVSUNG B., "Targeting inflammatory pathways for prevention and therapy of cancer: Short-term friend, long-term foe", Clin Cancer Res, (20090000), vol. 15, pages 425 - 430
    - APTE R NDVORKIN TSONG XFIMA E et al., "Opposing effects of IL-1 alpha and IL-1 beta on malignancy patterns. Tumor cell-associated IL-1 alpha potentiates anti-tumor immune responses and tumor regression, whereas IL-1 beta potentiates invasiveness", Adv. Exp. Med. Biol., (20000000), vol. 479, pages 277 - 288
    - BALKWILL FRMANTOVANI A., "Cancer-related inflammation: common themes and therapeutic opportunities", Semin. Cancer Biol., (20120000), vol. 22, doi:10.1016/j.semcancer.2011.12.005, pages 33 - 40, XP028897445

DOI:   http://dx.doi.org/10.1016/j.semcancer.2011.12.005
    - BANI, M. R.GAROFALO, A.SCANZIANI, E.GIAVAZZI, R., "Effect of interleukin-1-beta on metastasis formation in different tumor systems", J. Natl. Cancer Ins., (19910000), vol. 83, no. 2, pages 119 - 123
    - BASU AKRADY JKLEVISON SW, "Interleukin-1: a master regulator of neuroinflammation", J Neurosci Res, (20040000), vol. 78, pages 151 - 156
    - BERSE, BHUNT JADIEGEL RJMORGANELLI PYEO KBROWN F et al., "Hypoxia augments cytokine (transforming growth factor-beta (TGFbeta) and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts", Clin. Exp. Immunol, (19990000), vol. 115, pages 176 - 182
    - BERGER PMCCONNELL JPNUNN M et al., "C-reactive protein levels are influenced by common IL-1 gene variations", Cytokine, (20020000), vol. 17, pages 171 - 174
    - CARMI, Y.VORONOV, E.DOTAN, S.LAHAT, N.RAHAT, M. A.FOGEL, M. et al., "The role of macrophage-derived IL-1 in induction and maintenance of angiogenesis", J Immunol, (20090000), vol. 183, pages 4705 - 4714
    - CHEN HWILKINS LMAZIZ N et al., "Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context", Hum Mol Genet, (20060000), vol. 15, doi:10.1093/hmg/ddi469, pages 519 - 529, XP002437353

DOI:   http://dx.doi.org/10.1093/hmg/ddi469
    - COUSSENS LMWERB Z., "Inflammation and cancer", Nature, (20020000), vol. 420, pages 60 - 867
    - DINARELLO C A, "Biologic basis for interleukin-1 in disease", Blood, (19960000), vol. 87, no. 6, pages 2095 - 2147, XP000574933
    - FARROW BEVERS BM., "Inflammation and the development of pancreatic cancer", Surg Oncol, (20020000), vol. 10, pages 153 - 169
    - FEDERICO AMORGILLO FTUCCILLO CCIARDIELLO FLOGUERCIO C, "Chronic inflammation and oxidative stress in human carcinogenesis", Int. J. Cancer, (20070000), vol. 121, pages 2381 - 86
    - FERNANDES JVFERNANDES TAADE AZEVEDO JCVCOBUCCI RNO et al., "Link between chronic inflammation and human papillomavirus-induced carcinogenesis (Review", Oncology Letters, (20150000), vol. 9, pages 1015 - 1026
    - GRIVENNIKOV SIGRETEN FRKARIN M, "Immunity, inflammation, and cancer", Cell, (20100000), vol. 140, doi:10.1016/j.cell.2010.01.025, pages 883 - 899, XP055369021

DOI:   http://dx.doi.org/10.1016/j.cell.2010.01.025
    - HE QFU YTIAN DYAN W., "The contrasting roles of inflammasomes in cancer", Am J Cancer Res, (20180000), vol. 8, no. 4, pages 566 - 583
    - HUSSAIN SPHARRIS CC., "Inflammation and cancer: An ancient link with novel potentials", Int. J. Cancer, (20070000), vol. 121, pages 2373 - 80
    - JENG JHWANG YJCHIANG BLLEE PHCHAN CP et al., "Roles of keratinocyte inflammation in oral cancer: Regulating the prostaglandin E2, interleukin-6 and TNF-alpha production of oral epithelial cells by areca nut extract and arecoline", Carcinogenesis, vol. 24, pages 1301 - 1315
    - JUNG YJ1ISAACS JSLEE STREPEL JNECKERS L., "IL-lbeta-mediated up-regulation of HIF-1 alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis", FASEB j, (20030000), vol. 17, no. 14, pages 2115 - 17
    - KIYOHARA, CHORIUCHI TTAKAYAMA KNAKANISHI Y., "IIL 10 rsl 143634 Polymorphism, Cigarette Smoking, Alcohol Use, and Lung Cancer Risk in a Japanese Population", J Thorac Oncol, (20100000), vol. 5, pages 299 - 304
    - KRELIN Y et al., "Interleukin-lbeta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors", Cancer Res, (20070000), vol. 67, pages 1062 - 71
    - KURTZMAN SHANDERSON KHWANG Y et al., "Cytokines in human breast cancer: IL-1 alpha and IL-lbeta expression", Oncol Rep, (19990000), vol. 6, pages 65 - 70
    - LANDVIK NEHART KHAUGEN AZIENOLDDINY S, "Functional analysis of a lung cancer risk haplotype in the IL1B gene regulatory region", J Hum Genet, (20120000), vol. 57, pages 747 - 752
    - LANDVIK NEHART KSKAUG VSTANGELAND LBHAUGEN AZIENOLDDINY S, "A specific interleukin-1B haplotype correlates with high levels of IL1B mRNA in the lung and increased risk of non-small cell lung cancer", Carcinogenesis, (20090000), vol. 30, pages 1186 - 1192
    - LEE KMPARK SKHAMAJIMA NTAJIMA K et al., "Genetic polymorphisms of interleukin-1 beta (IL-1B) and IL-1 receptor antagonist (IL-1RN) and breast cancer risk in Korean women", Breast Cancer Res Treat, (20060000), vol. 96, no. 2, pages 197 - 202, XP019274996
    - LEE CHCHANG JSMSYU SHWONG TS, "IL-1 β Promotes Malignant Transformation and Tumor Aggressiveness in Oral Cancer", J Cell Physiol, (20150000), vol. 230, pages 875 - 884
    - LI YWANG LPAPPAN LGALLIHER-BECKLEY ASHI J., "IL-IØ promotes sternness and invasiveness of colon cancer cells through Zebl activation", Mol Cancer, (20120000), vol. 11, pages 87 - 99
    - LISS, C.FEKETE, M. J.HASINA, R.LAM, C. D.LINGEN, M. W., "Paracrine angiogenic loop between head-and-neck squamous-cell carcinomas and macrophages", Int. J. Cancer, (20010000), vol. 93, no. 6, pages 781 - 785
    - LIU QRUSSELL MRSHAHRIARI K et al., "Interleukin-1 beta promotes skeletal colonization and progression of metastatic prostate cancer cells with neuroendocrine features", Cancer Res, (20130000), vol. 73, pages 3297 - 305
    - LUST JADONOVAN KA, "The role of interleukin-1 beta in the pathogenesis of multiple myeloma", Hematol. Oncol. Clin. North Am., (19990000), vol. 13, pages 1117 - 25
    - LUST JA et al., "Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 10-induced interleukin 6 production and the myeloma proliferative component", Mayo Clin. Proc., (20090000), vol. 84, pages 114 - 22, XP055695323
    - MARUYAMA, K.MORI, Y.MURASAWA, S.MASAKI, H.TAKAHASHI, N.TSUTUSMI, Y. et al., "Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases", J. Mol. Cell. Cardiol, (19990000), vol. 31, pages 607 - 617
    - MICHAUD, D. S. et al., "Periodontal disease assessed using clinical dental measurements and cancer risk in the ARIC study", JNCI J Natl Cancer Inst, (20180000), vol. 110, no. 8, page djx278
    - MITSUNAGA SIKEDA MSHIMIZU SOHNO IFURUSE J et al., "Serum levels of IL-6 and IL-Iβ can predict the efficacy of gemcitabine in patients with advanced pancreatic cancer", Br J Cancer, (20130000), vol. 108, no. 10, pages 2063 - 9
    - MOHR THAUDEK-PRINZ VSLANY AGRILLARI JMICKSCHE MGERNER C, "Proteome profiling in IL-Iβ and VEGF-activated human umbilical vein endothelial cells delineates the interlink between inflammation and angiogenesis", PLoS ONE, (20170000), vol. 12, no. 6, page e0179065
    - NADINI ACARRARO F, "Role of Inflammatory Mediators in Angiogenesis", Curr Drug Targ- Inflamm & Allergy, (20050000), vol. 4, pages 3 - 8
    - NASU, K.ITOH, H.YUGE, A.KAWANO, Y.YOSHIMATSU, J.NARAHARA, H., "Interleukin-lbeta regulates vascular endothelial growth factor and soluble fmslike tyrosine kinase-1 secretion by human oviductal epithelial cells and stromal fibroblasts", Gynecol. Endocrinol, (20060000), vol. 22, pages 495 - 500
    - NUTTER FHOLEN IBROWN HKCROSS SSEVANS CAWALKER MCOLEMAN REWESTBROOK JASELBY PJBROWN JE et al., "Different molecular profiles are associated with breast cancer cell homing compared with colonisation of bone: evidence using a novel bone-seeking cell line", Endocr Relat Cancer, (20140000), vol. 21, pages 327 - 341
    - OHSHIMA, M. TATEMICHIT. SAWA., "Chemical basis of inflammation-induced carcinogenesis", Archives of Biochemistry and Biophysics, (20030000), vol. 417, no. 1, doi:10.1016/S0003-9861(03)00283-2, pages 3 - 11, XP004444532

DOI:   http://dx.doi.org/10.1016/S0003-9861(03)00283-2
    - OHNISHI SMA NTHANAN RPINLAOR S et al., "DNA Damage in Inflammation-Related Carcinogenesis and Cancer Stem Cells", Oxid Med Cell Longev, (20130000), vol. 2013, page 387014
    - OZBABACAN SEAGURSOY ANUSSINOV RKESKIN O, "The Structural Pathway of Interleukin 1 (IL-1) Initiated Signaling Reveals Mechanisms of Oncogenic Mutations and SNPs in Inflammation and Cancer", PLoS Comput Biol, (20140000), vol. 10, no. 2, page el003470
    - PELETEIRO BLUNET NCARRILHO CDURAES C et al., "Association Between Cytokine Gene Polymorphisms and Gastric Precancerous Lesions: Systematic Review and Meta-analysis", Cancer Epidemiol Biomarkers Prev, (20100000), vol. 19, no. 3, pages 62 - 76
    - RAO SKPAVICEVIC ZDU ZKIM JGFAN MJIAO YROSEBUSH MSAMANT SGU WPFEFFER LM, "Pro-inflammatory genes as biomarkers and therapeutic targets in oral squamous cell carcinoma", J Biol Chem, (20100000), vol. 285, pages 32512 - 21
    - ROGUS JBECK JDOFFENBACHER S et al., "IL1B gene promoter haplotype pairs predict clinical levels of interleukin-lbeta and C-reactive protein", Hum Genet, (20080000), vol. 123, pages 387 - 398, XP019631027
    - SANABRIA-SALAS MCHERNANDEZ-SUAREZ GUMANA-PEREZ A et al., "IL1B-CGTC haplotype is associated with colorectal cancer in admixed subjects with increased African ancestry", Sci Rep, (20170000), vol. 7, page 41920
    - SCHNEIDER SROSS AGRICHNIK JM, "Do inflammatory pathways drive melanomagenesis?", Experiment Dermat, (20140000), vol. 24, pages 86 - 90
    - STAVRI GTZACHARY I CBASKERVILLE P AMARTIN, J FERUSALIMSKY J D., "Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia", Circulation, (19950000), vol. 92, pages 11 - 14
    - TAKAHASHI HOGATA HNISHIGAKI RBROIDE DHMICHAEL KARIN M., "Tobacco Smoke Promotes Lung Tumorigenesis by Triggering IKKβ and JNK1-Dependent Inflammation", Cancer Cell, (20090000), vol. 17, pages 89 - 97
    - TANG RFWANG SXZHANG FR et al., "Interleukin-l alpha, 6 regulate the secretion of vascular endothelial growth factor A, C in pancreatic cancer", Hepatobiliary Pancreat Dis Int, vol. 4, pages 460 - 63
    - TARASSISHIN LLIM JWEATHERLY DBANGELETTI RHLEE SC, "Interleukin-1-induced changes in the glioblastoma secretome suggest its role in tumor progression", J Proteomics, (20140000), vol. 99C, doi:10.1016/j.jprot.2014.01.024, pages 152 - 168, XP028625154

DOI:   http://dx.doi.org/10.1016/j.jprot.2014.01.024
    - TARASSISHIN LCASPER DLEE SC, "Aberrant Expression of Interleukin-lb and Inflammasome Activation in Human Malignant Gliomas", PLoS ONE, (20140000), vol. 9, no. 7, page e103432
    - THORNTON PPINTEAUX EGIBSON RMALLAN SMROTHWELL NJ, "Interleukin-1-induced neurotoxicity is mediated by glia and requires caspase activation and free radical release", JNeurochem, (20060000), vol. 98, pages 258 - 266
    - VINCENZI BPATTI GGALLUZZO SPANTANO F et al., "Interleukin 1B-51 IT gene (IL1B) polymorphism is correlated with gastric cancer in the Caucasian population: Results from a meta-analysis", Oncology Reports, (20080000), vol. 20, pages 1213 - 1220
    - VORONOV ECARMI YAPTE RN, "The role of IL-lintumor-mediated angiogenesis", Frontiers Physiol, (20140000), vol. 5
    - WANG LLIU ZLI Y et al., "Pro-inflammatory cytokine interleukin-ip promotes the development of intestinal stem cells", Inflamm Res, (20120000), vol. 61, pages 1085 - 1092
    - WANG LZHANG LFWU JXU SJXU YY et al., "IL-lb-Mediated Repression of microRNA-101 Is Crucial for Inflammation-Promoted Lung Tumorigenesis", Cancer Res, (20140000), vol. 74, no. 17, pages 4720 - 30
    - WANG YWANG KHAN GCWANG RX et al., "Neutrophil infiltration favors colitis-associated tumorigenesis by activating the interleukin-1 (IL-1)/IL-6 axis", Nature, (20140000), vol. 7, no. 5, pages 1106 - 15
    - WEINREICH, D. M.ELARAJ, D. M.PUHLMANN, M.HEWITT, S. M. et al., "The role of interleukin 1 in growth and metastasis of human cancer xenografts", Cancer Res, (20030000), vol. 63, no. 18, pages 5957 - 5961
    - WHITCOMB, DAVID C., "Inflammation and Cancer. V. Chronic pancreatitis and pancreatic cancer", Am J Physiol Gastrointest Liver Physiol, (20040000), vol. 287, pages G315 - G319
    - WOLF JSCHEN ZDONG G et al., "IL (interleukin)-1 alpha promotes nuclear factor-kappaB and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas", Clin Cancer Res, (20010000), vol. 7, pages 1812 - 20
    - XU J1YIN ZCAO SGAO W et al., "Systematic review and meta-analysis on the association between IL-1B polymorphisms and cancer risk", PLoS One, (20130521), vol. 8, no. 5, page e63654
    - XU HDING QJIANG HW, "Genetic polymorphism of interleukin-1A (IL-1A), IL-1B, and IL-1 receptor antagonist (IL-1RN) and prostate cancer risk", Asian Pac J Cancer Prev, (20140000), vol. 15, no. 20, pages 8741 - 7
    - LEE, C. H.S. H. SYUK. J. LIUP. Y. CHUW. C. YANGP. LINW. Y. SHIEH, "Interleukin-1 beta transactivates epidermal growth factor receptor via the CXCL1-CXCR2 axis in oral cancer", Oncotarget, (20150000), vol. 6, no. 36, pages 38866 - 38880
    - MICHAUD et al., JNCI Natl Cancer Inst, (20180000), vol. 11, no. 8, page djx278
 US20050095849
 US20180604278
 US19360604456
 US19940604454
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.